Non-Hodgkin's Lymphoma Clinical Trials

A listing of Non-Hodgkin's Lymphoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294-3300

A clinical research study of Nivolumab and Brentuximab Vedotin for the treatment of Non-Hodgkin's Disease/Lymphomas (CheckMate 436)

UPDATED

Birmingham Alabama 35211

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

Arizona

UPDATED

Phoenix Arizona 85259

A clinical trial seeking patients for a research study for the treatment of Non-Hodgkin's Lymphoma, Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

California

UPDATED

Encinitas California 92024-1332

A clinical research study of ABP 798 and Rituximab for the treatment of Lymphoma, Non-Hodgkin

UPDATED

Los Angeles California 90027

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

UPDATED

Los Angeles California 90095

Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma

UPDATED

Palo Alto California 94304

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

UPDATED

Palo Alto California 94304

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

View More ▼

UPDATED

Vallejo California 94589

A clinical research study of ABP 798 and Rituximab for the treatment of Lymphoma, Non-Hodgkin

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial seeking patients for a research study for the treatment of Non-Hodgkin's Lymphoma, Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

Connecticut

UPDATED

New Haven Connecticut 06510

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

District of Columbia

UPDATED

Washington District of Columbia 20010

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

Florida

UPDATED

Miami Florida 33136

A clinical research study of Nivolumab and Brentuximab Vedotin for the treatment of Non-Hodgkin's Disease/Lymphomas (CheckMate 436)

UPDATED

Tampa Florida 33612

A clinical research study of Nivolumab and Brentuximab Vedotin for the treatment of Non-Hodgkin's Disease/Lymphomas (CheckMate 436)

UPDATED

Tampa Florida 33612-9497

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

Georgia

UPDATED

Atlanta Georgia 30322

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

UPDATED

Atlanta Georgia 30342

Patients are needed to participate in a clinical research study to evaluate T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia

Illinois

UPDATED

Chicago Illinois 60637

A clinical research study of Nivolumab and Brentuximab Vedotin for the treatment of Non-Hodgkin's Disease/Lymphomas (CheckMate 436)

UPDATED

Chicago Illinois 60637

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

UPDATED

Urbana Illinois 61801

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

Iowa

UPDATED

Ames Iowa 50010

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

Kentucky

UPDATED

Louisville Kentucky 40207

A clinical trial seeking patients for a research study for the treatment of Non-Hodgkin's Lymphoma, Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

UPDATED

Louisville Kentucky 40207

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

Mount Sterling Kentucky 40353

A clinical research study of ABP 798 and Rituximab for the treatment of Lymphoma, Non-Hodgkin

Maryland

UPDATED

Lutherville Maryland 21093

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

Massachusetts

UPDATED

Boston Massachusetts 02215

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

Michigan

UPDATED

Grand Rapids Michigan 49503

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

Minnesota

UPDATED

Minneapolis Minnesota 55407

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

UPDATED

Rochester Minnesota 55905

A clinical research study of Nivolumab and Brentuximab Vedotin for the treatment of Non-Hodgkin's Disease/Lymphomas (CheckMate 436)

UPDATED

Rochester Minnesota 55905

A clinical trial seeking patients for a research study for the treatment of Non-Hodgkin's Lymphoma, Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

Mississippi

UPDATED

Jackson Mississippi 39216

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

Missouri

UPDATED

St. Louis Missouri 63110

A clinical research study of Nivolumab and Brentuximab Vedotin for the treatment of Non-Hodgkin's Disease/Lymphomas (CheckMate 436)

Montana

UPDATED

Billings Montana 59102

A clinical research study of ABP 798 and Rituximab for the treatment of Lymphoma, Non-Hodgkin

New Jersey

UPDATED

Hackensack New Jersey 07601

Patients are needed to participate in a clinical research study to evaluate T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia

New York

UPDATED

Bronx New York 10467

A clinical trial seeking patients for a research study of BPX-501 T cells and AP1903 and AP1903

UPDATED

New York New York 10029

A clinical research study of Nivolumab and Brentuximab Vedotin for the treatment of Non-Hodgkin's Disease/Lymphomas (CheckMate 436)

UPDATED

New York New York 10065

A clinical research study of Nivolumab and Brentuximab Vedotin for the treatment of Non-Hodgkin's Disease/Lymphomas (CheckMate 436)

UPDATED

New York New York 10065

A clinical trial to evaluate treatments for patients with Non-Hodgkin's Lymphoma

UPDATED

New York New York 10065

Patients are needed to participate in a clinical research study of ADCT-301 to evaluate Hodgkin Lymphoma or Non-Hodgkin Lymphoma

View More ▼

UPDATED

New York New York 10065

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)

UPDATED

New York New York 10016

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

UPDATED

New York New York 10065

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

UPDATED

Rochester New York 14642

A clinical research study of Nivolumab and Brentuximab Vedotin for the treatment of Non-Hodgkin's Disease/Lymphomas (CheckMate 436)

North Carolina

UPDATED

Cary North Carolina 27513

A clinical trial seeking patients for a research study for the treatment of Non-Hodgkin's Lymphoma, Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

UPDATED

Charlotte North Carolina 28204

A clinical research study of Nivolumab and Brentuximab Vedotin for the treatment of Non-Hodgkin's Disease/Lymphomas (CheckMate 436)

UPDATED

Charlotte North Carolina 28204

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

UPDATED

Winston-Salem North Carolina 27103

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

Ohio

UPDATED

Canton Ohio 44718

Patients are needed to participate in a clinical research study of Copanlisib (BAY 80-6946), Placebo and Rituximab to evaluate Non-Hodgkin's Lymphoma (iNHL)